dual primer PCR
Co-Diagnostics Inks Agreement with Biosearch for Primer-Dimer Technology
Co-Diagnostics will license its CoPrimers technology to Biosearch to make, use, market, and sell the primer-dimer-reducing oligonucleotides.
The sensitivity of real-time PCR-based testing of dried blood spots is too low to use the method as a routine test for CMV infection in newborns. Despite this, PCR testing of other bodily fluids such as saliva still holds promise for such a test.